JDD in the Media

Could You Be Allergic to Additives?

By December 30, 2019February 14th, 2020No Comments
A recent article from US News, “Could You Be Allergic to Additives?” cites a January 2013  JDD study  on whether common additives in food or medications can cause reactions in some people.
The study, “Medication Dyes as a Source of Drug Allergy,” states “Excipients are defined as inert substances added to a drug or food to confer a suitable consistency, appearance, or form. They may be added for bulk, to change dissolution or the kinetics of absorption, to improve stability, to influence palatability, or to create a distinctive appearance. The last function may depend heavily on the use of coloring agents, especially when there are multiple dosages (such as with warfarin), and dose confusion may result in profound complications. While described as inert, excipients have been associated with triggering immunological reactions, although this is almost never considered in common practice when patients have reactions to medications, even when they appear to react to many different and distinct drugs.”
Read Article Now

You May Also Like

Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
October 17, 2024

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
September 24, 2024

Dermatology Roundup: National Eczema Association Aims to Define “Flare”

By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…
AcneAtopic DermatitisFeatured ArticlesJDD HighlightsJDD in the MediaPsoriasisSkin of ColorThe Latest
September 19, 2024

JDD in the News: Benefits of Long-Term Ixekizumab in Psoriasis; Secukinumab in Psoriasis Patients with Skin of Color

by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…

Leave a Reply